Breaking
Friday, June 19, 2026

Licensing News

🇺🇸 FDA

FDA breaking news and regulatory updates for BD, investors, and analysts

Showing 1–12 of 12 articles

High impact NewsJun 12, 2026

Socioeconomic status shapes children’s brain development, study finds

4 min

Dr. Sarah Mitchell
High impact NewsJun 11, 2026

Takeda TYK2 drug tops Bristol Myers’ Sotyktu in psoriasis head-to-head test

psoriasis · 5 min

Dr. Sarah Mitchell
High impact NewsJun 11, 2026

AstraZeneca expands obesity push as it invests $125M in ultrasound medicine

FDA · obesity · 5 min

Dr. Sarah Mitchell
Critical impact NewsJun 8, 2026

Tillomed Laboratories update: pipeline, melphalan and next catalysts

oncology · 6 min

Dr. Sarah Mitchell
Critical impact NewsJun 7, 2026

Sanofi completes Inhibrx acquisition for $1.7B

inflammation · 4 min

Dr. Sarah Mitchell
High impact NewsJun 4, 2026

Fierce Biotech Week 2026: Key Insights and Highlights

FDA · 6 min

Dr. Sarah Mitchell
High impact NewsJun 3, 2026

Vir Biotechnology Stock: Board Reshuffle and Governance Votes Post-AGM

FDA · 7 min

Dr. Sarah Mitchell
High impact NewsJun 3, 2026

Hanmi Signs Licensing Deal with Eli Lilly for Sonefpeglutide, Bolstering GLP-2 Pipeline

FDA · 4 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

Longeveron Stockholder Letter Outlines 2026 Strategy and Partnership Focus

FDA · 6 min

Dr. Sarah Mitchell
High impact NewsMay 1, 2026

Pharma Partnering US: $77.3B Licensing Deals in Q1 2026

biotech · 12 min

Dr. Sarah Mitchell
Critical impact NewsApr 29, 2026

Pharma Partnering US: Biotech Dealmaking Heats Up

biotech · 8 min

Dr. Sarah Mitchell
Critical impact NewsApr 28, 2026

FDLI 2026: FDA Leaders to Discuss Strategic Priorities

general · 3 min

Dr. Sarah Mitchell